Introduction way to structure-function analyses of PrP. In earlier experiments, we showed that in Prnp o/o mice overexpresPrP, the prion protein, plays a central role in the pathosion of truncated PrP transgenes encoding PrP with a genesis of transmissible spongiform encephalopathies deletion of codons 32-80 (inclusive) and therefore resuch as scrapie or bovine spongiform encephalopathy taining only one of the five octarepeats, sustained repli-(BSE) (Prusiner, , 1998 
, 1985). There is overwhelming
However, incubation times are longer and result in prion evidence that a modified form of PrP C , which we desigtiters in brain and spleen that are lower than in wildnate as PrP* (Weissmann, 1991), is the principal if not type mice in all stages of the disease. Interestingly, even the only component of the infectious agent, or prion in terminally ill mice, no histopathological changes were and that it is devoid of nucleic acid. The "protein-only" evident in the brain at the level of light microscopy; hypothesis (Griffith, 1967) states that the abnormal form however, there was neuronal loss and astrogliosis in the cervical spinal cord. Thus, while the octarepeat sequence is not essential for sustaining prion replication Samples from uninfected or RML-infected, terminally ill mice were analyzed by Western blotting before (A and B) or after phosphotungstate (NaPTA) precipitation (C and D) as described in Experimental Procedures, using antisera 6H4 for PrP. (A) Brain homogenates from uninfected mice; the blots were also stained with antibody 22C11 for APP, which served as internal control. Figure 1A ; Table 1 ). The distribution of the truncated PrP in brain and brainstem ure 4A). Moreover, there was a reduction in the number of motor neurons in the Rexed laminae VIII and IX of was similar to that of full-length PrP in wild-type mice (Figure 2A ). Mice of both lines remained healthy without the spinal cord. In the cervical spinal cord levels C4-C8, the motor neuron reduction of about 10%-25% in inany neurological signs for over 800 days.
Quantification was as described in the Experimenal Procedures section. (B) Brain homogenates from RML-infected, terminally ill mice without (Ϫ) and after (ϩ) proteinase K treatment. (C) Brain homogenates of noninoculated
fected C4/C4 mice was similar to that of infected wildtype and tga20/tga20 mice, as compared with ageSusceptibility to Mouse Prions of PrP Knockout matched mock infected mice ( Figure 4B Blots were treated with 100 g/ml proteinase K (100) or not treated (0). While PrP Sc is present throughout the cerebrum, cerebellum, and brainstem of RML-infected, wild-type mice (first column), it is found mainly in the thalamus and brainstem of terminally ill tga20/tga20 mice (second column) and C4/ C4 mice (third column) inoculated with RML scrapie. Brains of tga20/tga20 mice (fourth column) infected with 1% brain homogenate from terminally ill C4/C4 mice (which had originally been infected with RML inoculum) exhibit proteinase K-resistant PrP immunostaining indistinguishable from that of RMLinfected tga20/tga20 brains (second column). (Table 2) . A mouse homozygous RML-inoculated C4/C4 compared to wild-type mice, they are the same in spinal cord. for the Prnp ⌬32-93 cluster (C4/C4), sacrificed 4 months after inoculation, had a titer of about 2 log LD 50 U/ml PrP⌬32-93-Expressing Brain Grafts Propagate Prions 10% brain homogenate but no significant infectivity in and Remain Devoid of Scrapie-like Pathology the spleen (Table 2) . After 8 months, when clinical sympTo further investigate pathogenesis in brain tissue extoms were apparent, the titer in the pooled brain homogpressing PrP⌬32-93, embryonal neuroectodermal tisenates of 2 C4/C4 mice was about 7 log LD 50 U/ml 10% sue from C4/C4 mice was grafted (Isenmann et al., 1996) homogenate and in the spleen infectivity was at borderinto the caudoputamen of adult Prnp o/o mice and inoculine detectability (about 2.5 log LD 50 U/ml 10% homogelated i.c. with RML prions ( Figure 5 ). As reported earlier, nate). Similarly low titers were also found in brain and tga20/tga20 grafts (6/6) showed strong neuronal loss, spleen of a terminally ill C15/Ϫ mouse analyzed (Table  spongiosis, (tga20/tga20) with 1% brain homogenates from RML-or that of the recipient may cause disease after a much RML-C4-infected, sick mice caused scrapie after similar longer incubation time than prions from a donor with the incubation times, namely 68 days (Table 2) . same sequence, a phenomenon designated as "prion Estimated titers in brains of C4/C4 mice inoculated transmission barrier" and considered to be equivalent with RML or C4/C4-passaged RML were about 7 and to the naturally occurring "species barriers" (Scott et 6.7 LD 50 U/ml 10% homogenate, respectively. Thus, the al., 1989). Because the difference between PrP⌬32-93 moderate pathological changes in the brains of C4/C4 and wild-type PrP might cause a prion transmission mice inoculated with C4/C4-passaged RML were not barrier, brain homogenates pooled from two RMLassociated with a higher prion titer than that in RMLinfected, sick C4/C4 mice were inoculated into C4/C4 inoculated C4/C4 mice, which had no discernible brain mice to overcome such a conjectural barrier. However, pathology (Table 2) . In this regard, passaging RML once all inoculated mice (6/6) succumbed to scrapie after through C4/C4 mice did not change its properties. 244 Ϯ 16 days, that is, after a delay similar to that resulting after RML infection, namely 232 Ϯ 21 (Table 1) . Thus, RML passaged once through C4/C4 mice did not Discussion result in reduced incubation time; however, it did give rise to moderate spongiosis in the brainstem ( Figure 3M ) and mild reactive astrocytosis in thalamus and brain-
The N-terminal half of PrP contains a conserved region of tandem repeats of an eight amino acid sequence stem of three C4/C4 mice analyzed (Figures 3F and 3M) , In this paper, we asked the question of whether the 10-30 times and protease-resistant and NaPTA-precipitable PrP about 30-50 times lower than in their wild-type octarepeat region of PrP is essential for sustaining prion replication and scrapie disease. We therefore introcounterparts. Because the transgenic mice expressed about four times more PrP than wild-type mice and duced into Prnp o/o mice PrP transgenes from which the segment comprising codons 32-93 had been deleted.
showed the same expression pattern, we conclude that the long incubation times and low prion and PrP Sc levels The resulting mature protein contained the first nine amino acids (retained, albeit unnecessarily as later are the consequence of the deletion. Considering that the scrapie form of truncated PrP has the same degree emerged [Supattapone et al., 1999], to ensure correct posttranslational processing) and was devoid of all octaof resistance to protease as that of full-length PrP, it seems unlikely that the low prion and PrP Sc levels are repeats. Two lines of mice homozyous for the transgene cluster, C4/C4 and C15/C15, expressed the truncated the result of more rapid turnover; rather, we believe that they are the consequence of a decrease in the PrP at about four times wild-type level and with the same overall distribution pattern as in wild type. Mice conversion rate of the truncated PrP. Strikingly, we were unable to discern histopathologihemizygous or homozygous for the cluster were challenged with mouse prions. All animals succumbed to cal lesions in brain and brainstem of terminally ill PrP⌬32-93 animals at the level of light microscopy, not scrapie-like disease, showing that the truncated PrP was competent in this regard. Interestingly, the animals even the astrogliosis that so far has been found in all murine scrapie disease. On the other hand, infectivity, showed front leg paresis rather than the usual hind leg symptoms. Incubation times to first symptoms (31-45 gliosis, and loss of motor neurons in the cervical segment of the spinal cord were similar in C4/C4 and wildweeks) and to terminal disease (34-53 weeks) were longer than for wild-type controls (22.5 and 24.5 weeks, type mice or in transgenic mice overexpressing fulllength PrP (tga20/tga20 Figure  1D , pellets were resuspended in 15.2 l PBS, 0.1% Sarkosyl and Oppenheim, 1995). digested with 50 g/ml proteinase K for 1 hr at 37ЊC. PMSF was added to 2 mM and loading buffer with ␤-mercaptoethanol was
